M6-C Artificial Disc: FDA IDE Pivotal Study

September 19, 2014

Status: This trial has been completed.


DISC is one of 12 sites in US, only in AZ where patients have access to the M6-C Artificial Disc: FDA IDE Pivotal Study.  If you are a patient who is interested in participating in this study, please contact DISC directly.

Study Objective

The primary objective is to evaluate the safety and effectiveness of the Spinal Kinetics M6-C artificial cervical disc in patients with symptomatic cervical radiculopathy with or without cord compression.

The Study is a prospective, concurrently controlled, multi-center study to evaluate the safety and effectiveness of the M6-C artificial cervical disc compared to anterior cervical discectomy and fusion (ACDF) for the treatment of symptomatic cervical radiculopathy. A total of 243 subjects will be treated; 162 M6-C subjects from up to 15 clinical sites, and 81 ACDF subjects at up to 5 clinical sites. The minimum required post-operative clinical evaluations of subjects will be conducted at 6 weeks, 3 months, 6 months, 1 year and 2 years. Evaluations beyond 2 years may be requested.

Who Will Qualify?

Patients eligible for the study will have a diagnosis of degenerative cervical radiculopathy with or without spinal cord compression requiring surgery at one level from C3 to C7, demonstrated by signs and/or symptoms of disc herniation and/or osteophyte formation (e.g. neck and/or arm pain, radiculopathy, etc.) and is confirmed by patient history and radiographic studies. Patients will have not adequately responded to conservative medical care over a period of at least six weeks. Patients must also be available for regular, scheduled follow-up visits by their treating physician for a minimum of two years post-surgery.

The M6-C Artificial Disc Study is now closed to enrollment due to completion.

Additional Information

More Detail on the Study Protocol

Previous Article2014 Fitz’s Supper Club Celebrities at Your Service Event Next ArticleIs back or neck pain holding you back?